Skip to content
Brand AI

WAKAMOTO

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2021

    Harrow Health finalizes MAQ-100 commercial-rights agreement

    Harrow Health finalized an agreement with Wakamoto Pharmaceutical to acquire commercial rights for MAQ-100 in the United States and Canada. Wakamoto retained marketing rights in other countries.

    Source